Exelixis Competitors and Similar CompaniesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Genocea Biosciences.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. | |
Founding Date | Founding Date 2003 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Cambridge, US HQ |
Employees | Employees 35037% increase | Employees 593% decrease |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 5.7 k |
Financial | ||
Revenue (est.) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $1.6m (FY, 2021) |
Net income | Net income ($194.9m) (FY, 2023) | Net income ($33.2m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 714m | Total funding raised $ 209.5m |
For sources of this data, please see the company profile
View Company Profiles
Genocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View company